STARD13-IT1

Across TCGA pan-cancer cohorts, STARD13-IT1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of STARD13-IT1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where STARD13-IT1 RNA is repressed in tumor relative to normal tissue. In most cancer types STARD13-IT1 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, KIRC, and KICH are the cancer types where STARD13-IT1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in STARD13-IT1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.328	<.001	8	view →
KIRC	All	II,III,IV	−0.175	<.001	8	view →
KICH	All	II,III,IV	−0.398	<.001	7	view →
KIRP	Male	All	−0.287	<.001	6	view →
PAAD	Male	All	+0.265	.017	2	view →
READ	All	III,IV	−0.180	.026	2	view →
LUSC	Female	All	−0.197	.024	1	view →
HNSC	Female	All	+0.060	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

STARD13-IT1–THCA

Open the THCA breakdown →